Clinical use of modern stress echocardiography in mitral valve diseases
Abstract
Current review contains data concerning the role of exercise or dobutamine stress echocardiography (stress-echo) in mitral valve diseases. Challenges of clinical impairment and necessity of surgical treatment in mitral stenosis are discussed. The clinical indications for stress testing are proposed. Clinical and hemodynamic parameters for stress-echo assessment are presented. The principles of test result interpretation, risk stratification and selection of patients for surgical treatment, based on stress-echo data, are summarized.
About the Authors
S. J. Bartosh-Zelenaya
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
T. V. Naiden
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
I. A. Shpynova
Medica Company
Russian Federation
Russian Federation
N. N. Kovaleva
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
References
1. Coisne A., Levy F., Malaquin D. et al. Feasibility of Doppler hemodynamic evaluation of primary and secondary mitral regurgitation during exercise echocardiography. International Journal of Cardiovascular Imaging. 2015; 31:291-299.
2. Garbi M., Chambers J., Vannan M.A., Lancellotti P. Valve stress echocardiography: a practical guide for referral, procedure, reporting, and clinical implementation of results from the HAVEC Group. Journal of American College of Cardiology: Cardiovascular Imaging. 2015; 8: 724-736.
3. Lancellotti P., Fattouch K, La Canna G. Therapeutic decision-making for patients with fluctuating mitral regurgitation. Nature Reviews Cardiology. 2015; 12: 212-219.
4. Lancellotti P., Magne J., Dulgheru R., Ancion A. et al. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. American Journal of Cardiology. 2015; 115:1454-1461.
5. Lancellotti P., Pellikka P. A., Budts W. EACVI/ ASE clinical recommendations. The use of stress echocardiography in non-ischaemic heart disease. Journal of American Society of Echocardiography. 2017; 30: 101-138.
6. Magne J., Mahjoub H., Dulgheru R. et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. European Heart Journal. 2014; 35:1608-1616.
7. Magne J., Pibarot P., Sengupta P. P. et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. Journal of American College of Cardiology: Cardiovascular Imaging. 2015; 8:83-99.
8. Naji P., Griffin B. P., Asfahan F. et al. Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography. Circulation. 2014; 129:1310-1319.
9. Nishimura R. A., Otto C. M., Sorajja P. et al. AHA/ACC Guideline for the management of patients with valvular heart disease. Circulation. 2014; 129(23):2441-2488.
10. Nishimura R.A., Otto C.M., Bonow R. O. et al. AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of American College of Cardiology. 2017; 70(2): 254-289.
11. Vahanian A., Alfiery O., Andreotti F. et al. ESC/EACTS Guidelines on the management of valvular heart disease. European Heart Journal. 2012; 33(19): 2451-2496.
Review
For citations:
Bartosh-Zelenaya S.J., Naiden T.V., Shpynova I.A., Kovaleva N.N. Clinical use of modern stress echocardiography in mitral valve diseases. Medical alphabet. 2018;1(14):38-44. (In Russ.)
Views:
294
Email this article 